Versant Venture Capital V, L.P. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Versant Venture Capital V, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Versant Venture Capital V, L.P.. Versant Venture Capital V, L.P. is a 10% Owner in Crinetics Pharmaceuticals, Inc. ($CRNX) and a 10% Owner in CRISPR Therapeutics AG ($CRSP) and a 10% Owner in Gritstone Oncology, Inc. ($GRTS).
Address: ONE SANSOME STREET, SUITE 3630 SAN FRANCISCO 94104 CA
Companies in which Versant Venture Capital V, L.P. is an Insider
Crinetics Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Versant Venture Capital V, L.P.: 10% Owner
Holdings: 2,524,456 shares
Latest Transaction: Feb 06 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CRISPR Therapeutics AG
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Versant Venture Capital V, L.P.: 10% Owner
Holdings: 1,519,505 shares
Current Value: $23,932,204
Latest Transaction: Apr 26 2018
$CRSP Market Capitalization: $605.88M
$CRSP Previous Close: $15.75
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Gritstone bio, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Versant Venture Capital V, L.P.: 10% Owner
Holdings: 3,102,929 shares
Latest Transaction: Oct 02 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Versant Venture Capital V, L.P.
Sentiment: All, CRNX, CRSP, GRTS
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 06 2019 | CRNX | Crinetics Pharmace ... | Versant Venture Capital V, L.P ... | 10% Owner | Sell | J | 0.00 | 678 | 0 | 0 | 678 to 0 (-100.00 %) |
| Feb 06 2019 | CRNX | Crinetics Pharmace ... | Versant Venture Capital V, L.P ... | 10% Owner | Buy | J | 0.00 | 678 | 0 | 678 | 0 to 678 |
| Feb 06 2019 | CRNX | Crinetics Pharmace ... | Versant Venture Capital V, L.P ... | 10% Owner | Sell | J | 0.00 | 9,473 | 0 | 0 | 9.5 K to 0 (-100.00 %) |
| Feb 06 2019 | CRNX | Crinetics Pharmace ... | Versant Venture Capital V, L.P ... | 10% Owner | Buy | J | 0.00 | 9,473 | 0 | 9,473 | 0 to 9.5 K |
| Feb 06 2019 | CRNX | Crinetics Pharmace ... | Versant Venture Capital V, L.P ... | 10% Owner | Sell | J | 0.00 | 33,903 | 0 | 192,122 | 226 K to 192.1 K (-15.00 %) |
| Feb 06 2019 | CRNX | Crinetics Pharmace ... | Versant Venture Capital V, L.P ... | 10% Owner | Sell | J | 0.00 | 14,828 | 0 | 84,161 | 99 K to 84.2 K (-14.98 %) |
| Feb 06 2019 | CRNX | Crinetics Pharmace ... | Versant Venture Capital V, L.P ... | 10% Owner | Sell | J | 0.00 | 13,387 | 0 | 75,949 | 89.3 K to 75.9 K (-14.99 %) |
View all Versant Venture Capital V, L.P. insider transactions.